期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肿瘤干细胞特性研究进展 被引量：4

暂未订购
导出
作者 冯海凉 刘玉琴
机构地区 中国医学科学院基础医学研究所中国协和医科大学基础医学院
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2008年第3期215-217,共3页 Cancer Research on Prevention and Treatment
基金 国家重点基础研究发展规划(973)资助项目(2002CB51300)
关键词 肿瘤 肿瘤干细胞 肿瘤治疗
分类号 R730 [医药卫生—肿瘤]
  • 相关文献

参考文献25

  • 1Virchow R.Celluar-pathologie[J]. Arch Pathol Anat Physio Klin Med, 1855,8(3) :3-39.
  • 2Kopper L, Hajdu M. Tumor Stem Cells[J]. Pathology Oncology Research, 2004, 10(2) :69-73.
  • 3Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a promitive hematopoietic cell[J]. Nature Med,1997,3(7) :730-737.
  • 4Blair A, Hogge DE, Ailles LE, et al. Lack of expression of Thy-1 (CD90) on actue myeloid leukemia cells with long-term proliferative ability in vitro and in vivo[J]. Blood, 1997,89(9) : 3104-3112.
  • 5Jordan CT, Upchurch D, Szilvassy SJ, et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells[J]. Leukemia, 2000, 14 (10) : 1777-1784.
  • 6Guzman ML, Jordan CT. Considerations for targeting malignant stem cells in leukemia[J]. Cancer Control, 2004, 11 (2) : 97-104.
  • 7Hauswirth AW, Florian S, Printz D, et al. Experssion of the target receptor CD33 in CD34/CD38/CD123 AML stem cells [J]. Eur J Clin Invest,2(107,37(1 ) :73-82.
  • 8任乐荣,刘玉琴,刘险峰,苏广彦,顾蓓,董继红.血液系统肿瘤细胞系中CD34^+干细胞特性研究[J].解剖学报,2005,36(4):367-371. 被引量：6
  • 9Clarke MF, Morrison SJ, Wieha MS, et al. Isolation and use of solid tumor stem cells[P]. United States Patent Application, 2002,200220119565.
  • 10Al-Hajj M,wicha MS,Benito-Hemandez A,et al. Prospective identification of tumorigenic breast cancer cells[J]. Proc Natl Acad Sci USA,2003,100(7) :3983-3988.

二级参考文献14

  • 1Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells[ J]. Proc Natl Acad Sci USA, 2003,100(7): 3983-3988.
  • 2Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors[J]. Cancer Res,2003,63(18) :5821-5828.
  • 3Laurenti L, Sica S, Sora F, et al. Long-term immune recovery after CD34+ immunoselected and unselected peripheral blood progenitor cell transplantation: a case-control study[J]. Haematologica, 1999,84(12):1100-1103.
  • 4Dao MA,Nolta JA,CD34:to select or not to select? That is the question[J]. Leukemia, 2000,14 (5): 773-776.
  • 5Vescio RA, Hong CH, Cao J. et al. The hematopoietic stem cell antigen,CD34, is not expressed on the malignant cells in multiple myeloma[ J].Blood, 1994,84 ( 10 ): 3283-3290.
  • 6Cozzio A, Passegue E, Ayton PM, et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors[J]. Genes Dev ,2003,17(24) :3029-3035.
  • 7Tsuchiya T, Hagihara M, Shimakura Y, et al. The generation of immunocompetent dendritic cells from CD34 + acute myeloid or lymphoid leukemia cells [ J ]. Iht J Hematol, 2002,75 ( 1 ): 55-62.
  • 8Kreider BL, Benezra R, Rovera G, et al. Inhibition of myeloid differentiation by the helix-loop-helix protein Id[ J]. Science, 1992,255(5052): 1700-1702.
  • 9Sun XH. Constitutive expression of the Id1 gene impairs mouse B cell development [ J ]. Cell, 1994,7 ( 5 ): 893 -900.
  • 10Wolf NS, Kone A, Priestley GV, et al. In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection [J]. Exp Hematol, 1993,21 (5) :614-622.

共引文献5

同被引文献53

  • 1钱波,蔡寒青,冯洁.干细胞、肿瘤干细胞与肿瘤发生[J].世界华人消化杂志,2007,15(13):1526-1531. 被引量：7
  • 2Mimeault M, Batra SK. Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer. Gut, 2008,57 (10) :1456-1468.
  • 3Kasper S. Exploring the origins of the normal prostate and prostate cancer stem cell. Stern Cell Rev, 2008,4 (3) :193-201.
  • 4Sell S. Alpha-fetoprotein, stem cells and cancer: how study of the production of alpha-fetopratein during chemical hepatocarcinogenesis led to reaffirmation of the stem cell theory of eaucer. Tumour Biol, 2008,29(3) :161-180.
  • 5Liao L, Zhao RC. An overview of stem cell-based clinical trials in China. Stem Cells Dev, 2008,17 (4) :613-618.
  • 6Yip S, Shah K. Stem-cell based therapies for brain tumors. Curr Opin Mol Ther, 2008,10(4) :334-342.
  • 7Ofran Y, Ritz J. Targets of tumor immunity after allogeneie hematopoietic stem cell transplantation. Clin Caneer Res, 2008, 14(16) :4997-4999.
  • 8Ren G, Zhang L, Zhao X,et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Ceil, 2008,2 (2) : 141-150.
  • 9Prigozhina TB, Khitrin S, Elkin G, et al. Mesenchymal stromal cells lose their immanosuppressive potential after allotransplantation. Exp Hematol, 2008,36(10) :1370-1376.
  • 10Takahashi K, Tanabe K, Ohniki M, et al. Induction of Pluripotent Stem ceils from adult huaman fibroblasts by difined factors. Cell, 2007, doi : 10. 1016/j, cell. 2007.11. 019.

引证文献4

二级引证文献5

肿瘤防治研究
2008年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部